These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12067768)

  • 41. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
    Anderson VC; Burchiel KJ
    Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-related side effects of long-term intrathecal morphine therapy.
    Ruan X
    Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioids in non-cancer pain: a life-time sentence?
    Dellemijn PL
    Eur J Pain; 2001; 5(3):333-9. PubMed ID: 11558990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia.
    New T; Venable C; Fraser L; Rosenberg E; Schmidt J; James-Herry A; Osunkwo I; Dampier C
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e398-402. PubMed ID: 24136017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critically appraised paper: In patients with acute low back or neck pain, a judicious short course of opioids did not reduce pain compared with placebo [commentary].
    Langford A
    J Physiother; 2023 Oct; 69(4):272. PubMed ID: 37673723
    [No Abstract]   [Full Text] [Related]  

  • 46. Management of chronic intractable angina - spinal opioids offer an alternative therapy.
    Cherry DA; Gourlay GK; Eldredge KA
    Pain; 2003 Mar; 102(1-2):163-6. PubMed ID: 12620607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Case Report: Opioid Therapy for Chronic Low Back Pain].
    Schnabel A; Haaga R; Rittner HL
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Apr; 53(4):306-313. PubMed ID: 29742789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of strong opioids in the treatment of cancer pain in adults and children].
    Sorge J
    Klin Padiatr; 1989; 201(4):333-6. PubMed ID: 2570883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 50. Death after initiation of intrathecal drug therapy for chronic pain: assessing risk and designing prevention.
    Rathmell JP; Miller MJ
    Anesthesiology; 2009 Oct; 111(4):706-8. PubMed ID: 20029248
    [No Abstract]   [Full Text] [Related]  

  • 51. High-dose tramadol in comparison to low-dose morphine for cancer pain relief.
    Grond S; Radbruch L; Meuser T; Loick G; Sabatowski R; Lehmann KA
    J Pain Symptom Manage; 1999 Sep; 18(3):174-9. PubMed ID: 10517038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of severe cancer pain via spinal catheters].
    Andersen JS; Markers PI; Valentin N
    Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
    Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus.
    Kronenberg MF; Laimer I; Rifici C; Saltuari L; Bramanti P; Moriggl U; Norer B; Kofler A
    Pain; 1998 Apr; 75(2-3):383-7. PubMed ID: 9583774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cognitive effects of opioids].
    Grisart J
    Rev Med Suisse; 2009 Jun; 5(208):1356-8, 1360-3. PubMed ID: 19626760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.
    Samolsky Dekel BG; Tomasi M; Vasarri A; Gori A; Adversi M; Castagnoli A; Di Nino G; Melotti RM
    J Opioid Manag; 2014; 10(1):29-38. PubMed ID: 24604567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations.
    Ueberall MA; Mueller-Schwefe GH
    Curr Med Res Opin; 2015; 31(7):1413-29. PubMed ID: 25942606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Strong opioids and constipation].
    Schwarzer A; Nauck F; Klaschik E
    Schmerz; 2005 Jun; 19(3):214-9. PubMed ID: 15004747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the role of the kidneys in the pathogenesis of edema formation during permanent morphine application/an experimental study in rats.
    Supanz S; Likar R; Liebmann PM; Wintersteiger R; Sittl R; Sadjak A
    Arzneimittelforschung; 2004; 54(5):259-64. PubMed ID: 15212187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.